Vagus Nerve Stimulation for Moderate-to-Severe Rheumatoid Arthritis

clinical trial

Wikidata entity: Q106977400



Quantities

P4135maximum age75
P2899minimum age22
P1132number of participants250

P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P17 country ... Q30 (United States) United States
P582 end time ... 2023-07-01 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P1050 medical condition ... Q170990 (arthritis) arthritis
P4844 research intervention ... Q810254 (disease-modifying antirheumatic drug) disease-modifying antirheumatic drug
P6153 research site ... Q30269736 (Clinical Trials of Texas) Clinical Trials of Texas
P6153 research site ... Q30270033 (PMG Research) PMG Research
P6153 research site ... Q1472663 (University of Alabama at Birmingham) University of Alabama at Birmingham
P8005 research subject recruitment status ... Q76649708 (recruiting) recruiting
P1813 short name Monolingualtext RESET-RA ???
P580 start time ... 2021-01-11 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext A Randomized, Sham-Controlled, Double-Blind Study of Vagus Nerve Stimulation for Moderate-to-Severe Rheumatoid Arthritis: The RESET-RA Study ???

External Ids
P3098ClinicalTrials.gov IDNCT04539964

Why not click here or view trends?

log id: 5446103